Impact of left ventricular end-diastolic pressure as a marker for diastolic dysfunction on long-term outcomes in

Mariia Emelianova1, Vanessa Sciacca2, Regine Brinkmann1

  • 1Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.

Insights

Elevated left ventricular end-diastolic pressure (LVEDP) after transcatheter aortic valve replacement (TAVR) predicts long-term mortality. Pulmonary hypertension and tricuspid regurgitation also increase mortality risk in TAVR patients.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Diagnostics

Background:

  • Severe aortic stenosis necessitates transcatheter aortic valve replacement (TAVR).
  • Diastolic function assessment is crucial for predicting outcomes post-TAVR.
  • Left ventricular end-diastolic pressure (LVEDP) is a key hemodynamic parameter.

Purpose of the Study:

  • To determine the prevalence of elevated post-TAVR LVEDP.
  • To evaluate elevated LVEDP as a predictor of long-term mortality after TAVR.
  • To identify other predictors of mortality in TAVR patients.

Main Methods:

  • Retrospective analysis of 3328 patients undergoing TAVR.
  • Stratification into normal (<15 mmHg) and elevated (≥15 mmHg) post-procedural LVEDP groups.
  • Multivariate analysis to identify independent predictors of mortality.

Main Results:

  • Elevated post-procedural LVEDP was observed in 72.3% of patients.
  • Five-year mortality was significantly higher in the elevated LVEDP group (27.4% vs. 8.3%).
  • Independent predictors of mortality included elevated LVEDP, tricuspid regurgitation, and pulmonary hypertension.

Conclusions:

  • Elevated post-procedural LVEDP is an independent predictor of all-cause mortality post-TAVR.
  • Pulmonary hypertension and tricuspid regurgitation also predict mortality.
  • Diastolic dysfunction is a critical factor influencing TAVR outcomes and management decisions.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
15
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
22
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14